Clinuvel Pharmaceuticals Limited (ADR)
General ticker "CLVLY" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $377.1M (TTM average)
Clinuvel Pharmaceuticals Limited (ADR) follows the US Stock Market performance with the rate: 26.9%.
Estimated limits based on current volatility of 1.6%: low 7.68$, high 7.94$
Factors to consider:
- Company pays dividends (annually): last record date 2025-09-08, amount 0.03$ (Y0.38%)
Short-term CLVLY quotes
Long-term CLVLY plot
Financial data
| YTD | 2024-06-30 | 2025-06-30 |
|---|---|---|
| Operating Revenue | AUD88.18MM | AUD95.02MM |
| Operating Expenses | AUD40.17MM | AUD49.28MM |
| Operating Income | AUD48.01MM | AUD45.73MM |
| Non-Operating Income | AUD2.67MM | AUD5.82MM |
| Interest Expense | AUD4.45MM | AUD4.46MM |
| Income(Loss) | AUD50.68MM | AUD51.55MM |
| Taxes | AUD15.04MM | AUD15.38MM |
| Profit(Loss)* | AUD71.27MM | AUD72.35MM |
| Stockholders Equity | AUD203.01MM | AUD240.81MM |
| Inventory | AUD10.63MM | AUD8.82MM |
| Assets | AUD231.12MM | AUD271.75MM |
| Operating Cash Flow | AUD37.05MM | AUD41.10MM |
| Capital expenditure | AUD5.58MM | AUD0.30MM |
| Investing Cash Flow | AUD-29.03MM | AUD-47.72MM |
| Financing Cash Flow | AUD-3.57MM | AUD-2.94MM |
| Earnings Per Share** | AUD1.43 | AUD1.44 |
| Ordinary share to ADR | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.